Article: Boston Biomedica Awarded Two Additional US Patents for Pressure Cycling Technology (PCT).

Seventh and eighth patents target sterilization of biological materials and

purification of nucleic acids

WEST BRIDGEWATER, Mass., Aug. 21 /PRNewswire/ --

Boston Biomedica, Inc. (Nasdaq: BBII) today announced that it has been issued two additional patents by the United States Patent and Trademark Office for the use of its proprietary Pressure Cycling Technology (PCT) to sterilize biological materials and purify nucleic acids. The first patent, "Rapid Cryobaric Sterilization and Vaccine Preparation" (US Patent No. 6,270,723), describes the use of high pressure to sterilize materials such as vaccines, therapeutics, or blood plasma preparations ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!